Active Status

Reset

Delivery Type

Reset

Duration Type

Reset

Developer

Reset

User

Reset

Mode

Reset

Project Stage

Reset

Potential MPT

Reset

API

Reset

Switch to table view to see breakout by user and hormonal/non-hormonal.

Displaying 1 - 10 of 56
Alternative Name: 11b-methyl-19-nortestosterone 17b-dodecylcarbonate (11b-MNTDC)
Active Status: Active
User: Male
Mode: Hormonal
Delivery Method: Injectable, Oral
Partner: BIOQUAL, Inc.
Project Stage: Lead Optimization
Project Phase: Targets and Early Development
Alternative Name: 2-Arachidonoylglycerol Hydrolase, Monoacylglycerol Lipase ABHD2, Lung Alpha/Beta Hydrolase 2, Protein PHPS1-2, LABH2, Alpha/Beta Hydrolase Domain Containing Protein 2,Testicular Tissue Protein Li 6, EC 3.1.1, PHPS1-2, HS1-2
Target
Role in reproduction: Sperm Motility
Active Status: Unknown
User: Female, Male
Mode: Hormonal
Delivery Method: Vaginal Gel, Vaginal Ring, Other
Project Stage: Target Identification
Project Phase: Targets and Early Development
Alternative Name: Acrosomal Protein SP-10, Sperm Protein 10, D11S4365, SPACA2, SP-10
Target
Role in reproduction: Sperm-Egg Interaction
Active Status: Unknown
User: Female
Mode: Non-hormonal
Delivery Method: Intrauterine, Vaginal, Other
Project Stage: Target Validation
Project Phase: Targets and Early Development
Alternative Name: GnRH II Receptor Antagonists
Active Status: Unknown
Mode: Hormonal
Partner: CICRR, San Antonio, CONRAD
Project Stage: Compound ID/Selection
Project Phase: Targets and Early Development
Alternative Name: DAM Metallopeptidase Domain 2, Cancer/Testis Antigen 15, Disintegrin And Metalloproteinase Domain-Containing Protein 2, Fertilin Subunit Beta, PH30-Beta, FTNB, CT15, PH30, Fertilin Beta, EC 3.4.24, PH-30b, CRYN1, CRYN2, PH-30
Target
Role in reproduction: Spermatogenesis
Active Status: Unknown
User: Female, Male
Mode: Non-hormonal
Delivery Method: Injectable, Testicular, Vaginal, Other, Vas Deferens
Project Stage: Target Validation
Project Phase: Targets and Early Development
Alternative Name: AF-2364
Role in reproduction: Spermatogenesis
Active Status: Active
User: Male
Mode: Non-hormonal
Partner: Population Council
Project Stage: Lead Optimization
Project Phase: Targets and Early Development
Alternative Name: Calpain-7-Like Protein, C6orf103, Chromosome 6 Open Reading Frame 103, CAPN16, CAPN7L
Target
Active Status: Unknown
User: Female, Male
Mode: Non-hormonal
Project Stage: Target Identification
Project Phase: Targets and Early Development
Role in reproduction: Sperm-Egg Interaction
Active Status: Active
User: Male
Mode: Non-hormonal
Delivery Method: Oral
Partner: Norfolk State University
Project Stage: Lead Optimization
Project Phase: Targets and Early Development
Active Status: Active
User: Female
Mode: Non-hormonal
Delivery Method: Vaginal, Other
Partner: University of Cincinnati
Project Stage: Lead Optimization
Project Phase: Targets and Early Development
Active Status: Unknown
User: Female
Mode: Hormonal
Delivery Method: Subdermal
Partner: Murdoch University
Project Stage: Prototype Development
Project Phase: Targets and Early Development

Pages

Displaying 1 - 10 of 121
Active Status: Unknown
User: Female
Mode: Non-hormonal
Delivery Method: Intrauterine
Partner: Shandong Provincial Institute, China, Technology for Family Planning, China
Project Stage: Pre-clinical
Project Phase: Pre-Clinical and Clinical Development
Alternative Name: Inhibitors of Testicular Retinoic Acid Biosynthesis
Active Status: Active
User: Male
Mode: Non-hormonal
Delivery Method: Oral
Partner: University of Washington, University of Minnesota
Project Stage: Pre-clinical
Project Phase: Pre-Clinical and Clinical Development
Active Status: Active
User: Female
Mode: Non-hormonal
Delivery Method: Vaginal Gel
Partner: Evofem, Inc.
Project Stage: Phase III
Project Phase: Pre-Clinical and Clinical Development
Alternative Name: ARC; triple hormone contraceptive; Triple OC
Active Status: Active
User: Female
Mode: Hormonal
Delivery Method: Oral
Partner: ANI Pharmaceuticals, Pantarhei Bioscience
Project Stage: Phase II
Project Phase: Pre-Clinical and Clinical Development
Alternative Name: Suspensories
Active Status: Inactive
User: Male
Mode: Non-hormonal
Delivery Method: Testicular
Partner: Centre Hospitalier Universitaire de Toulouse, France
Project Stage: Phase II
Project Phase: Pre-Clinical and Clinical Development
Active Status: Active
User: Female
Mode: Hormonal
Delivery Method: Subdermal
Partner: FHI 360, Yale University
Project Stage: Pre-clinical
Project Phase: Pre-Clinical and Clinical Development
Active Status: Unknown
User: Female
Mode: Hormonal
Delivery Method: Subdermal
Partner: Peking University, Institute of Biomedical Engineering at Chinese Academy of Medical College
Project Stage: Pre-clinical
Project Phase: Pre-Clinical and Clinical Development
Active Status: Active
User: Female
Mode: Hormonal
Delivery Method: Subdermal
Partner: Shanghai Institute of Planned Parenthood Research (SIPPR)
Project Stage: Pre-clinical
Project Phase: Pre-Clinical and Clinical Development
Active Status: Inactive
User: Female
Mode: Hormonal
Delivery Method: Subdermal
Partner: University of Washington
Project Stage: Pre-clinical
Project Phase: Pre-Clinical and Clinical Development
Alternative Name: BDADs
Active Status: Inactive
User: Female, Male
Mode: Non-hormonal
Delivery Method: Oral
Partner: Focused Scientific, University of Washington
Project Stage: Pre-clinical
Project Phase: Pre-Clinical and Clinical Development

Pages

Displaying 1 - 10 of 49
Alternative Name: Smaller/Nulliparous Copper IUD, Liberté TT380 Short, Micro T
Active Status: Active
User: Female
Mode: Non-hormonal
Delivery Method: Intrauterine
Partner: 7Med Industrie, France
Project Stage: SRA/WHO PQ Approved
Project Phase: Limited Market Availability
Alternative Name: SILCS Diaphragm
Active Status: Active
User: Female
Mode: Non-hormonal
Delivery Method: Barrier
Partner: PATH, CONRAD, SILCS, Inc., Kessel Marketing & Vertriebs GmbH
Project Stage: SRA/WHO PQ Approved
Project Phase: Limited Market Availability
Alternative Name: Saheli; Ormeloxifene
Active Status: Active
User: Female
Mode: Non-hormonal
Delivery Method: Oral
Partner: Central Drug Research Institute, India, HLL Lifecare Limited
Project Stage: Marketed
Project Phase: Limited Market Availability
Active Status: Active
User: Female
Mode: Non-hormonal
Delivery Method: Intrauterine
Partner: Chongqing Medical Equipment Factory Co., Ltd.
Project Stage: Marketed
Project Phase: Limited Market Availability
Alternative Name: Nanocomposite Copper (Cu) IUD
Active Status: Active
User: Female
Mode: Non-hormonal
Delivery Method: Intrauterine
Partner: Tongji Medical College at Huazhong University of Science and Technology
Project Stage: Marketed
Project Phase: Limited Market Availability
Alternative Name: l'Amour®; Jeitosa®
Active Status: Active
User: Female
Mode: Non-hormonal
Delivery Method: Barrier
Partner: Cupid Ltd.
Project Stage: SRA/WHO PQ Approved
Project Phase: Limited Market Availability
Active Status: Active
User: Female
Mode: Non-hormonal
Delivery Method: Barrier
Partner: Cupid Ltd.
Project Phase: Limited Market Availability
Active Status: Active
User: Female
Mode: Hormonal
Delivery Method: Injectable
Partner: Concept Foundation, Sun Pharmaceuticals, India, WHO HRP, PT. Tunggal Idaman Abdi
Project Stage: SRA/WHO PQ Approved
Project Phase: Limited Market Availability
Active Status: Active
User: Female
Mode: Hormonal
Delivery Method: Injectable
Partner: DKT International, PT Harsen
Project Stage: Marketed
Project Phase: Limited Market Availability
Active Status: Active
User: Female
Mode: Hormonal
Delivery Method: Oral
Partner: HRA Pharma
Project Stage: SRA/WHO PQ Approved
Project Phase: Limited Market Availability

Pages

CSV